EGF and neoplasm: Given that EGF signaling is constitutively activated in many tumor types [111] including in the liver of patients with HCC [112, 113], EGF signaling may be an important step in liver cancer pathogenesis and that its attenuation by SCFAs may, in part, contribute to the delay in dysplasia and liver cancer [39].